AI tool study to predict chemotherapy side effects and symptoms
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This study tests an artificial-intelligence (AI) tool in a phone app that helps predict side effects and symptoms from chemotherapy. It may help patients and their care team plan and respond to side effects more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 20 or older
- Have lung, head and neck, or esophageal cancer
- Be starting chemotherapy soon (before or after surgery) or having chemotherapy for cancer that returned or spread
- Be well enough to do daily activities (ECOG 0 to 2, as your cancer team rates it)
- Have your own smartphone and be able to use the app yourself
- Agree to understand the study and participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This trial tests if an AI-powered system can help monitor and manage side effects during chemotherapy for breast or colorectal cancer. If you are starting chemotherapy and can report your symptoms, this study may offer extra support.
This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.
This trial tests a mobile app that uses artificial intelligence to help women with early-stage breast cancer manage symptoms during their first chemotherapy. The app is in Arabic and is designed to make it easier to report how you're feeling and get support.
This study tests a smartphone application designed to help you monitor and manage side effects and symptoms while you're receiving chemotherapy or other systemic treatment for breast cancer, colorectal cancer, or lymphoma. The app may help your doctors catch problems early and support you throughout your treatment.
This study tests a smartphone app designed to help lung cancer patients track and manage side effects while receiving combination drug therapy at home. The app learns from your symptom patterns to provide personalized support during your treatment.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.